Compass Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ANAB
AnaptysBio, Inc. |
$15.30 | $640.07 M | -3.82 | 136 | $91.28 M |
![]() AVTE
Aerovate Therapeutics, Inc. |
$2.70 | $597.48 M | -6.84 | 30 | $0 |
![]() CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
![]() ELVN
Enliven Therapeutics, Inc. |
$24.07 | $984.95 M | -11.97 | 57 | $0 |
![]() FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
![]() GOSS
Gossamer Bio, Inc. |
$1.09 | $124.06 M | -0.65 | 135 | $0 |
![]() GPCR
Structure Therapeutics Inc. |
$27.50 | $2.47 B | -23.59 | 163 | $0 |
![]() IDYA
IDEAYA Biosciences, Inc. |
$25.69 | $2.88 B | -19 | 131 | $7.00 M |
![]() IVA
Inventiva S.A. |
$2.20 | $185.39 M | -1.34 | 123 | $17.48 M |
![]() KRON
Kronos Bio, Inc. |
$0.97 | $44.62 M | -0.37 | 62 | $6.29 M |
![]() KROS
Keros Therapeutics, Inc. |
$15.64 | $1.76 B | -9.45 | 169 | $3.55 M |
![]() LYRA
Lyra Therapeutics, Inc. |
$0.22 | $19.53 M | -0.27 | 88 | $1.56 M |
![]() MGTX
MeiraGTx Holdings plc |
$6.34 | $306.74 M | -4.01 | 389 | $14.02 M |
![]() MLTX
MoonLake Immunotherapeutics |
$51.75 | $2.62 B | -57.88 | 100 | $0 |
![]() NAMS
NewAmsterdam Pharma Company N.V. |
$25.85 | $1.74 B | -7.15 | 68 | $45.56 M |
![]() NVCT
Nuvectis Pharma, Inc. |
$6.61 | $116.38 M | -4.5 | 13 | $0 |
![]() PEPG
PepGen Inc. |
$3.68 | $537.15 M | -5.11 | 81 | $0 |
![]() PRTC
PureTech Health plc |
$18.69 | $809.08 M | -12.47 | 90 | $3.33 M |
![]() REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
![]() TYRA
Tyra Biosciences, Inc. |
$16.06 | $1.04 B | -11.7 | 49 | $0 |
![]() VIGL
Vigil Neuroscience, Inc. |
$1.80 | $172.89 M | -2.17 | 66 | $0 |